Robert A. Krance, MD
Department or Service
- Texas Medical Center
Director, Bone Marrow Transplant / Stem Cell Transplant Program
Chief, Bone Marrow Transplant Clinic
Professor, Department of Pediatrics, Section of Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine
|St. Jude Children's Research Hospital||fellowship||Hematology-Oncology||1977|
|St. Jude Children's Research Hospital||residency||Pediatrics||1975|
|Rocky Mountain College||residency||Pediatrics||1972|
|Rush University Medical Center||residency||Pediatrics||1972|
|Rocky Mountain College||internship||Pediatrics||1971|
|Rush University Medical Center||internship||Pediatrics||1971|
|Loyola University of Chicago||medical school||Doctor of Medicine||1970|
About Robert A. Krance
Dr. Robert Krance is the Director of the Pediatric Bone Marrow Transplant (BMT)/Stem Cell Transplant Program at Texas Children’s Hospital. The clinical program, one of the most active in the country, treats patients with various hematologic, oncologic, immunologic and genetic disorders. Dr. Krance coordinates the clinical activities of the cell and gene therapy and the pediatric bone marrow transplant programs. Current initiatives focus on the development of transplantation using alternative donors and less than fully HLA matched related donors. Investigations are under way into the use of antibodies directed against hematopoietic cells and methods of stem cell purification. In collaboration with other investigators in the Center for Cell and Gene Therapy (CAGT), new cell based approaches are being conducted hopefully to diminish the impact of viral infection post transplantation.
His clinical interests include bone marrow transplantation and cell and gene therapy.
His research interests include: 1) the development of transplantation using alternative donors, 2) transplantation using less than fully HLA matched related donors, and 3) the impact of viral infection post-transplantation.
Dr. Krance is board certified by the American Board of Pediatrics in pediatric medicine and by the American Board of Pediatrics-Hematology/Oncology
|American Academy of Pediatrics (AAP)||Member|